SUNY, Dept . of Peds, 'Brooklyn, NY . D e s p i t e l a r g e numbers of c h i l d r e n with chronic r e n a l f a i l u r e , t h e r e i s i n s u f f i c i e n t information about GF p r i o r t o end s t a g e r e n a l d i s e a s e .
I t has been s t a t e d t h a t a GFR (ml/min/1.73~2) of 20-25 i s t h e t h r e s h o l d below which growth r e t a r d a t i o n begins.
We r e p o r t t h e l i n e a r growth i n 11 p r e p u b e r t a l c h i l d r e n w i t h s t a b l e MRI f o r a t l e a s t I y e a r (34.4224.4 mos., mean S D ) .
Height was measured w i t h a w a l l s t a d i o m e t e r . MRI was defined a s a GFR between 20-40.
The GFR was a s s e s s e d u s i n g t h e endogenous c r e a t i n i n e c l e a r a n c e o r a l e n g t h e s t i m a t i o n . There were 7 male and 4 female p a t i e n t s , mean age 9.3 y e a r s a t o n s e t . Six c h i l dr e n had c o n g e n i t a l and 5 had acquired c a u s e s of MRI. The GFR was i n i t i a l l y 32.5+6.4 and d e c l i n e d t o 26.7+6.5 a t t h e end of follow-up.
The mean serum ~a * was 9.4, PO;=^ .4 mg/dL and HCO3-23.8 m~q /~. The PTH l e v e l was e l e v a t e d i n a l l 7 c h i l d r e n w i t h t h e determination.
During t h e o b s e r v a t i o n p e r i o d , 9/11 c h i l d r e n s u f f e r e d GF. T h e i r mean cumulative l o s s of s t a t u r e f o r age was 0 . 6 5 9 . 4 4 SD.
The h e i g h t SD f e l l a t a mean y e a r l y r a t e of 0 . 2 5 5 1 . T h i s i s n e a r l y 65% of t h e mean annual l o s s of l e n g t h f o r age i n d i a l y s i s p a t i e n t s , a s r e p o r t e d by t h e lDTA R e g i s t r y . We conclude t h a t 1) s t a b l e MRI i s a s s o c i a t e d with p r o g r e s s i v e l o s s of l i n e a r growth f o r age; and 2) t h e degree of GF approaches t h a t obsenred i n c h i l d r e n on maintenance hemodialysis. Hyperparathyroidism and chronic metabolic a c i d o s i s may be c o n t r i b u t i n g f a c t o r s t o t h i s GF.
of the USA Collaborative Study of Reflux in Children.* VUR accounts for 15% of children and young adults with ESRD and i t is a common cause of severe hypertension in the same population. Since 1980, we have conducted an international, prospective, randomized trial of early anti-reflux surgery (S) vs. medical therapy (MI, namely, continous antibiotic chemoprophylaxis. The study population consists of children up t o 10 years of age with primary VUR, grade IV/V (International Classification). The end points of t h e trial are: I) renal growth, a s measured by planimetry, 2) progression of renal scarring or development of new scars, 3) individual kidney GFR, a s measured by DMSA renal scans, 4) r a t e of resolution of VUR in patients treated medically, 5) incidence of UTI, 6) incidence of hypertension. To date, 300 pts. have been enrolled. Preliminary analysis of the 116 USA pts. has yielded the following information: 42% of pts have a t least I renal scar a t entry; new or progressive scars were seen in 36% of M p t s vs 50% of S p t s when entry urograms were compared to those done 6 mo. later (p > .1). By 18 mo. of follow-up, grade IVlV VUR was still present in 83% of t h e pts in t h e M group. The incidence of a c u t e pyelonephritis was I per 0.007 pt-months a t risk in the S group, and 0.013 for M p t s (p >.I). Only I p t has developed BP > 95th percentile for age and sex during 1 8 mo. follow-up. Six pts allocated to M have undergone anti-reflux surgery because of recurrent UTIs and I p t allocated to S has required reoperation for persistent VUR. Thus, no dramatic differences in course between M and S a r e apparent a t this early analysis. The hypertension appears t o be mediated i n p a r t by r e n i n .
For t h i s reason c a p t o p r i l , an a n g i o t e n s i n converting enzyme i n h i b i t o r , i s a p p r o p r i a t e and experience with i t s use i n a few i n d i v i d u a l p a t i e n t s h a s been r e p o r t e d .
We present t h e s u c c e s s f u l management of hypertension by c a p t o p r i l i n 4 p a t i e n t s with HUS. P e r t i n e n t d a t a a r e summarized:
Pre-Cap. ( t a f t e r 18 mos. on c a p t o p r i l ) I n p a t i e n t s 1 and 2 c a p t o p r i l alone was used during t h e a c u t e d i s e a s e . I n p a t i e n t s 3 and 4 c a p t o p r i l with a d i u r e t i c was e f f e c t i v e f o r management of chronic hypertension present more than a year following the a c u t e i l l n e s s .
C a p t o p r i l may produce hyperkalemia v i a a l d o s t e r o n e i n h i b it i o n .
Serum potassium was modestly e l e v a t e d i n p a t i e n t s 1 and 2 but resolved a f t e r d i s c h a r g e d e s p i t e continued c a p t o p r i l therapy.
Renal f u n c t i o n a s determined by c r e a t i n i n e d i d not d e t e r i o r a t e upon i n s t i t u t i o n o f c a p t o p r i l .
I n summary, c a p t o p r i l i s e f f e c t i v e i n both a c u t e and chronic hypertension r e l a t e d t o HUS.
CARNITINE LOSSES I N CHILDREN O N HEMODIALYSIS (HD) AND

A&2 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) .
l V V J Gaston Z i l l e r u e l o , Michael Freundlich, Milan Novak, J o s e Foradada, Carolyn Abitbol, Brenda Montane, J o s e S t r a u s s .
Deuartment of P e d i a t r i c s . U n i v e r s i t v of Miami. Miami. F l o r i d a . Hvoerlioidemia (HL). u a r t i c u l a r l v e l e v a t e d t r i e l v c e r i d e s (TG)
2 .
. , .
u A i s f r e q u e n t l y seen i n uremic p a t i e n t s undergoing d i a l y s i s . Carnit i n e p l a y s a n important r o l e i n t h e u t i l i z a t i o n of f a t t y a c i d s and, being a small molecule, i t s p o s s i b l e l o s s e s i n d i a l y s i s
e f f l u e n t may be a c o n t r i b u t i n g f a c t o r t o HL. We s t u d i e d s i m u l t aneous c o n c e n t r a t i o n s of f r e e c a r n i t i n e (FC) and t o t a l c a r n i t i n e (TC) i n plasma ( p r e and p o s t HD) and d i a l y s i s e f f l u e n t i n 9 HD p a t i e n t s (f a g e : 18 years) and 5 CUD p a t i e n t s (x age 10 y e a r s ) .
Serum TG were determined i n a l l p a t i e n t s . R e s u l t s ( 2 + SD) a r e s u m a r i z e d i n t h e t a b l e ( t p <0.01 compared t o c o n t r o l s These r e s u l t s demonstrate: 1 ) s i g n i f i c a n t removal of TC during d i a l y s i s ( g r e a t e r on HD than CAPD) , but maintenance of normal plasma TC l e v e l s ; 2) s i g n i f i c a n t d e c r e a s e of plasma FC and TC immediately following HD and 3) HL with s i g n i f i c a n t e l e v a t i o n of TG i n both groups. It i s suggested t h a t cumulative Te l o s s e s d u r i n g d i a l y s i s may aggravate HL i n t h e s e p a t i e n t s .
PLASMA INFUSIONS (PI) IN THE MANAGEMENT OF HEMOLYTIC
1664 UREMIC SYNDROME (HUS). Gaston Z i l l e r u e l o , John J .
Byrnes, Michael F r e u n d l i c h , Carolyn Abithol, Brenda Montane and J o s e S t r a u s s . Departments of P e d i a t r i c s and Medicine, U n i v e r s i t y of Miami, Miami, F l o r i d a . I n s p i t e o f e a r l y d i a l y s i s and s u p p o r t i v e therapy, c h i l d r e n w i t h s e v e r e HUS have a high incidence of s e q u e l a e with c h r o n i c r e n a l f a i l u r e (CRF) a n d l o r hypertension. Previous experience a t t h i s c e n t e r has shown 66% of c h i l d r e n w i t h HUS developing CRF. S i n c e a plasma f a c t o r d e f i c i e n c y has been p o s t u l a t e d i n t h e pathogenesis of t h i s syndrome, we s t u d i e d t h e a c u t e and long term e f f e c t s of P I i n HUS. S i x c h i l d r e n (3 boys) 2-5 y e a r s of age w i t h HUS were t r e a t e d w i t h p e r i t o n e a l d i a l y s i s and P I .
Mean dose of P I was 25 ml/Kg/day given f o r 2-7 days. A l l c h i l d r e n had o l i g o a n u r i a >24 hours ( 2 d u r a t i o n 1 5 days; range 2-30 days) and thrombocytopenia (lowest p l a t e l e t count 2 17,500; range 8,000-40,000). Mean serum c r e a t i n i n e b e f o r e d i a l y s i s was 6.2 mgldl. T r a n s i e n t h y p t e r t e n s i o n was p r e s e n t i n a l l t h e p a t i e n t s and two had evidence of multi-organ involvement. A f t e r t h e i n i t i a l dose of P I , p l a t e l e t count r o s e t o >100,000 i n ii 4 days and o l i g oa n u r j a r e s o l v e d i n x 10 days. T o t a l d u r a t i o n of d i a l y s i s period was x 12 days (range 3-30 d a y s ) . At l a s t f o l l o w up ( 2 13 months) a l l s i x c h i l d r e n have serum c r e a t i n i n e c0.8 mg/dl (estimated GFR >75 ml/min/1.73 m2) and only two have mild hypertension and p r o t e i n u r i a . These r e s u l t s suggest t h a t j u d i c i o u s a d m i n i s t r at i o n of plasma has a b e n e f i c i a l e f f e c t i n HUS by a c c e l e r a t i n g recovery from t h e a c u t e phase and improving i t s f i n a l outcome. In ~e G ' s syndrome ( R S ) -t h e r e i s a.general decrease i n t h e spec i f i c a c t i v i t i e s of mitochondria1 enzymes, i n c l u d i n g two of t h e urea c y c l e , carbamyl phosphate s y n t h e t a s e and o r n i t h i n e carbamylt r a n s f e r a s e . These two enzymes c a t a l y z e t h e s y n t h e s i s o f c i t r u ll i n e (CIT) from o r n i t h i n e , NH3, and COe; t h e f u n c t i o n a l impairment o f t h i s r e a c t i o n sequence probably c o n t r i b u t e s t o hyperammonemia i n RS. S a l i c y l a t e (SA) has been implicated a s a s y n e r g i s t i c f a ct o r i n t h e pathogenesis of RS. In t h i s s t u d y we i n v e s t i g a t e d whether SA i n h i b i t s CIT s y n t h e s i s i n i s o l a t e d r a t l i v e r mitochond r i a . CIT s y n t h e s i s was assayed a t 370C by measuring 14c02 f i x at i o n i n t h e oresence o f o r n i t h i n e and NHa (ABB 178:19.1977 ). SA ; SA c o n c e n t r a t i o n , mM: 0 0.25 0 . 5 1.0-C i t r u l l i n e s y n t h e s i s :
2.69k.05 2.172.10 1.662.10 0.515.13 G e n t i s i c a c i d , s a l i c y l u r i c a c i d and acetaminophen had no e f f e c t a t 5 mM. CIT s y n t h e s i s i s dependent on matrix ATP: a mechanism o f i n h i b i t i o n was suggested by f u r t h e r experiments showing t h a t SA uncouoles o x i d a t i v e ohosohorvlation and d e c r e a s e s t h e r a t e o f ATP s y n t h e s i s . Matrix ATPIADP ra'tios were decreased by SA as f o l l o w s : 1 . 1 5 5 0 4 ( 0 SA); 0.90f.21 (0.25 mH SA); 0.631.09 (0.5 mM SA); 0.115.04 (1 mM SA). Conclusion: SA i s a p o t e n t i n h i b i t o r of CIT s y n t h e s i s a t physiological c o n c e n t r a t i o n s , probably a s a r e s u l t of i t s uncoupling a c t i o n which lowers m a t r i x ATP. The i m p l i c a t i o n f o r RS i s t h a t SA might i n h i b i t urea c y c l e f u n c t i o n beyond +he a1 ready compromised 1 eve1 . (NIH 14936) 
